Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares were up 1.8% on Tuesday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8%
The stock has a market cap of C$18.19 million, a price-to-earnings ratio of -1.21 and a beta of 1.22. The company has a fifty day simple moving average of C$0.58 and a 200-day simple moving average of C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- The gold chart Wall Street is terrified of…
- Trump’s “Ace Card” For Iran
- Gold’s Next Surge is Imminent
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
